TCS forms strategic partnership with L&G
TCS forms strategic partnership with L&G

TCS forms strategic partnership with L&G

Apurva Joshi Article rating: 2.5

Tata Consultancy Services Limited has announced that it has expanded its strategic partnership with Legal & General (L&G) to help L&G transform into a digital workspace, leveraging TCS' Machine First Delivery Model and design thinking approach.

Titan plummets on Q2FY20 business update
Titan plummets on Q2FY20 business update

Titan plummets on Q2FY20 business update

Amir Shaikh Article rating: 4.4

In response to Titan’s Q2FY20 quarter update, the stock of Titan fell as much as 7 per cent to touch intra-day low of Rs. 1177.75 apiece.

Black Rose Industries begins commercial production of polyacrylamide liquids
Black Rose Industries begins commercial production of polyacrylamide liquids

Black Rose Industries begins commercial production of polyacrylamide liquids

Nidhi Jani Article rating: 3.4

The company’s entry into the polyacrylamide business is expected to be a game changer for the Indian polyacrylamide industry. While polyacrylamide liquids are already produced in good volumes in India, the country still depends on imports for 99 per cent of its 100,000MT polyacrylamide solid demand.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 3.3

Overall volumes in futures & options currently stand at 1,33,63,361 contracts with a turnover of Rs. 8,66,676.50 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 4.5

Overall volumes in futures & options currently stand at 1,33,63,361 contracts with a turnover of Rs. 8,66,676.50 crore.

Index trend and stocks in action October 09, 2019
Index trend and stocks in action October 09, 2019

Index trend and stocks in action October 09, 2019

DSIJ Intelligence Article rating: 5.0

If Nifty falls below the 11,060 level, the next level support is placed at 10,890. Below this, there are chances it may test the prior lows.On the upside, the immediate resistance is placed at 200 DMA (11,264) and only by moving above this level will the bulls get confidence to move higher.

Glenmark Pharmaceuticals plummets on US FDA warning letter
Glenmark Pharmaceuticals plummets on US FDA warning letter

Glenmark Pharmaceuticals plummets on US FDA warning letter

Amir Shaikh Article rating: 5.0

Glenmark Pharmaceuticals has informed the bourses that US FDA has issued a warning letter for its Baddi facility at Himachal Pradesh. The said facility was inspected by US FDA during 15th to 20th April of 2019. 

Indoco Remedies gets USFDA approval for its Rasagiline ANDA
Indoco Remedies gets USFDA approval for its Rasagiline ANDA

Indoco Remedies gets USFDA approval for its Rasagiline ANDA

Apurva Joshi Article rating: 5.0

Indoco Remedies Limited has received the final approval for its Abbreviated New Drug Application (ANDA) for Rasagiline 0.5 mg and 1 mg tablets from the United States Food & Drug Administration (USFDA).

P2P Lending as an asset class: Should you cherish it?
P2P Lending as an asset class: Should you cherish it?

P2P Lending as an asset class: Should you cherish it?

DSIJ Intelligence Article rating: 4.0

There are various asset classes available in the market today. Now P2P lending has made its way to become one of them. So, should you consider investing via P2P lending? Let’s find out.

RSS
First30893090309130923094309630973098Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR